Kai S. Lipinski

An Oncolytic Adenovirus Vector Combining Enhanced Cell-to-Cell Spreading, Mediated by the ADP Cytolytic Protein, with Selective Replication in Cancer Cells with Deregulated <b> <i>Wnt</i> </b> Signaling

Károly Tóth, Hakim Djeha, Baoling Ying et al. · Cancer Research · 2004 · 52 citations · Full text

Medicine, Cancer Biology, Oncology +15

Characterization of a new Leishmania major strain for use in a controlled human infection model

Helen Ashwin, Jovana Sádlová, Barbora Vojtková et al. · Nature Communications · 2021 · 50 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

cAMP-independent Activation of the Adenovirus Type 12 E2 Promoter Correlates with the Recruitment of CREB-1/ATF-1, E1A12S, and CBP to the E2-CRE

Peter Fax, Kai S. Lipinski, Helmut Esche et al. · Journal of Biological Chemistry · 2000 · 34 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Optimization of a synthetic β-catenin-dependent promoter for tumor-specific cancer gene therapy

Kai S. Lipinski, Hakim Djeha, Jonathan M. Gawn et al. · Molecular Therapy · 2004 · 32 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Differences in the Interactions of Oncogenic Adenovirus 12 Early Region 1A and Nononcogenic Adenovirus 2 Early Region 1A with the Cellular Coactivators p300 and CBP

Kai S. Lipinski, Peter Fax, Barbara Wilker et al. · Virology · 1999 · 26 citations

Life Sciences, Molecular Biology, Molecular Genetics +14